FIELD: veterinary science.
SUBSTANCE: the present innovation deals with introducing cycloferon preparation in combination with immune preparation as rhoncoleucin which should be injected subcutaneously at the dosage of 20000 IU/kg body weight. As for cycloferon, it should be injected intramuscularly at the dosage of 25 mg/kg body weight. Moreover, the preparations mentioned should be injected once/3 d 5-fold. The innovation enables to increase efficiency of immunotherapy at canine oncological pathology.
EFFECT: higher efficiency of correction.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF OSTEOLYSIS IN METASTATIC SPREADING OF MALIGNANT FORM IN DOG BONE | 2005 |
|
RU2299738C1 |
METHOD OF TREATING MASTITIS IN COWS | 2010 |
|
RU2423990C1 |
METHOD OF THERAPY OF MASTITIS IN DOGS | 2012 |
|
RU2513998C1 |
METHOD OF TREATING CHRONIC OSTEOMYELITIS IN ANIMALS | 2008 |
|
RU2377011C1 |
METHOD OF TREATMENT OF OBSTRUCTIVE BRONCHITIS IN DOGS | 2015 |
|
RU2627446C2 |
METHOD FOR PREVENTION OF DYSPEPSIA AND CORRECTION OF IMMUNE HOMEOSTASIS IN NEWBORN CALVES | 2017 |
|
RU2661598C1 |
METHOD FOR TREATING HEPATOSIS COMPLICATED WITH MYOCARDIODYSTROPHIA IN DOGS | 2004 |
|
RU2261711C1 |
METHOD FOR TREATING MASTITIS IN COWS | 2002 |
|
RU2228176C2 |
METHOD FOR TREATING CHLAMYDIA CONJUNCTIVITIS IN CATS AND DOGS | 2003 |
|
RU2259848C2 |
METHOD FOR PREVENTING MASTITIS IN COWS DURING DRY PERIOD AND AFTER DELIVERY | 2005 |
|
RU2301663C1 |
Authors
Dates
2008-03-27—Published
2006-11-07—Filed